The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akari Therapeutics, Plc
Investors and Encourages Investors to Contact the Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased
Akari Therapeutics, Plc (“Akari” or the “Company”) (NASDAQ: AKTX) securities between March 30, 2017, and May 11, 2017, inclusive (the “Class Period”). Akari
investors have until July 11, 2017 to file a lead plaintiff motion.
Investors suffering losses on their Akari investments are encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On May 11, 2017, the Company announced that its CEO, Dr. Gur Roshwalb, was placed on administrative leave while the Akari Board
of Directors investigates whether Dr. Roshwalb had any involvement with a research report that contained material inaccuracies. On
this news, the Company’s share price fell more than 20% on May 12, 2017.
The complaint filed in this class action lawsuit alleges that throughout the Class Period, Defendants made materially false
and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and
prospects. Specifically, Defendants failed to disclose: (1) that the Company’s CEO, and possibly other executives, were involved in
publishing false information about the Company, including false information about the Phase 2 PNH trial of Coversin; (2) that the
Company lacked adequate checks and protections to prevent such behavior; and (3) that, as a result of the foregoing, Defendants’
statements about Akari’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
If you purchased shares of Akari during the Class Period you may move the Court no later than July 11, 2017 to
ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not
take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If
you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or
interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170515006412/en/